Abstract
Epilepsy, a chronic neurological illness, takes a heavy emotional toll on patients and their families. It is one of most neglected neurological illnesses in Africa. Studies have shown that epileptic seizures may be managed pharmacologically, behaviorally, and nutritionally. This study aims to investigate the therapeutic potential of combination of curcumin and aerobic exercise in treatment of epileptic seizure in rats. Four groups of Wistar strain albino rats; control, pilocarpine, pilocarpine + curcumin, and pilocarpine + curcumin + exercise was investigated to determine the effects of oral administration of curcumin and treadmill exercise on seizure frequency, activities of monoamine oxidase (MAO) and acetylcholinesterase (AChE), redox markers and Brain-Derived Neurotrophic Factor (BDNF) mRNA expression level in brain cortex and hippocampus of pilocarpine-induced epileptic rats. The results showed a significant reduction in the seizure frequency of rats treated with curcumin and curcumin + exercise groups, when compared with the pilocarpine-induced group. In addition, the significantly elevated MAO and AChE activities were ameliorated, coupled with a significant reduction in reactive oxygen species and thiol contents of the brain tissues of the pilocarpine-induced rats treated with curcumin plus exercise. Furthermore, the downregulated BDNF mRNA expression levels were significantly ameliorated in the induced groups treated with curcumin plus exercise. This study therefore, suggests that treadmill exercise could improve the therapeutic effects of curcumin in the management of epileptic seizure.
Similar content being viewed by others
SUPPLEMENTARY INFORMATION
Data associated with this study is available through the corresponding author upon reasonable request.
REFERENCES
Lawal, M., Omobayo, H., and Lawal K., British J. Neurosci. Nursing., 2018, vol. 14, no. 2, pp. 58–62.
McCance, K.L., Huether, S.E., Brashers, V.L., and Rote, N.S., Gen., 2016.
Pike, N. and McDaniel, N.L., Underst. Pathophysiol., 2017.
Arreguín-González, I.J., Cabrera-Castañón, R., and Ayala-Guerrero, F., Arch Neurociencias., 2017, vol. 22, no. 2, p. 152.
Olivier B., Phys Ther Sport., 2015, vol. 16, no. 2, pp. 105–106.
World Health Organization (WHO)., Epilepsy – Fact sheets. In: WHO. 2016.
World Health Organization (WHO). Epilepsy fact sheet. 2019. In: Epilepsy fact sheet. 2019.
Howard, G.M., Radloff, M., and Sevier, T.L., Curr. Sports Med Rep., 2004, vol.3, no. 1, pp. 15–19.
Kaufman, K.R. and Kaufman, N.D., Epileptic Disorders, 2013, vol. 15, no. 4, pp. 431–434.
Pimentel, J., Tojal, R., and Morgado, J., Seizure, 2015, vol. 25, pp. 87–94. Top of Form
Fountain, N.B. and May, A.C., Clin Sports Med., 2003, vol. 22, no. 3, pp. 611–627. [Internet]. Cited 2023 Feb 18.
Schmitt, B., Thun-Hohenstein, L., Vontobel, H., and Boltshauser, E., Neuropediatrics, 1994, vol. 25, no. 2, pp. 88–90. [Internet]. Cited 2023 Feb 18.
Camilo, F., Scorza, F.A., De Albuquerque, M., Vancini, R.L., Cavalheiro, E.A., and Arida, R.M., Arq. Neuropsiquiatr., 2009, vol. 67, no. 1, pp. 45–50.
Nakken, K.O., Løyning, A., Løyning, T., Gløersen, G., and Larsson, P.G., Epilepsia, 1997, vol. 38, no. 2, pp. 182–187.
Arida, R.M., de Almeida, A.C.G., Cavalheiro, E.A., and Scorza, F.A., Epilepsy Behav., 2013, vol. 29, no. 1, pp. 70–75.
Arida, R.M., Cavalheiro, E.A., and Scorza, F.A., Epilepsy Res., 2012, vol. 100, no. 3, pp. 245–254.
Walter, C., Murphy, B.L., Pun, R.Y.K., Spieles-Engemann, A.L., and Danzer, S.C., J. Neurosci., 2007, vol. 27, no. 26, pp. 7541–7552.
Johnson, E.L. and Kaplan, P.W., Semin. Neurol., 2020, vol. 40, no. 3, pp. 260–271.
Mello, L.E.A.M., Cavalheiro, E.A., Tan, A.M., Kupfer, W.R., Pretorius, J.K., Babb, T.L., et al., Epilepsia. 1993, vol. 34, no. 6, pp. 985–995.
Wozny, C., Kivi, A., Lehmann, T.N., Dehnicke, C., Heinemann, U., and Behr J., Sci., 2003, vol. 301, no. 5635, p. 463.
Knopp, A., Kivi, A., Wozny, C., Heinemann, U., and Behr, J., J.f Comp. Neurol., 2005, vol. 487, no. 4, pp. 349–370.
Henderson, K. W., Gupta, J., Tagliatela, S., et al., J. Neurosci., 2014, vol. 34, no. 44, pp. 14492–14504.
Zhou, H., Beevers, C. S., and Huang, S., Curr. Drug Targets, 2012, vol. 13, no. 3, pp. 524–535.
Wipperman, M.F., Montrose, D.C., Gotto, A.M. Jr., and Hajjar, D.P., Am. J. Pathol., 2019, vol. 189, no. 2, pp. 411–424.
Beevers, C.S., Li, F., Liu, L., and Huang, S., Int. J. Cancer, 2006, vol. 118, no. 2, pp. 262–270.
Kennedy, B.K. and Lamming, D.W., Cell Metab., 2016, vol. 23, no. 6, pp. 990–1003.
Lipton, J.O. and Sahin, M., Neuron., 2014, vol. 84, no. 2, pp. 275–291.
Hay, N. and Sonenberg, N., Genes Dev., 2004, vol. 18, no. 16, pp. 1926–945.
Galanopoulou, A.S., Gorter, J.A., and Cepeda, C., Epilepsia, 2012, vol. 53, Suppl 1, pp. 186–196.
Guo, D., Zeng, L., Brody, D.L., and Wong, M., PLoS One, 2013, vol. 8, no. 5, e64078.
Siebel, A.M., Menezes, F.P., Da Costa Schaefer, I., Petersen, B.D., and Bonan, C.D., Pharmacol. Biochem. Behav., 2015, vol. 135, pp. 89–96.
Drion, C.M., Borm, L.E., Kooijman, L., et al., Epilepsia, 2016, vol. 57, no. 8, pp. 1294–1303.
Al-Bishri, W.M., Abdel-Reheim, E.S., and Zaki, A.R., Asian Pac. J. Trop. Biomed., 2017, vol. 7, no. 6, pp. 545–553.
Akinyemi, A.J., Okonkwo, P.K., Faboya, O.A., et al., Metab. Brain Dis., 2017, vol. 32, no. 2, pp. 419–426.
Bali, A. and Jaggi, A.S., Eur. J. Pharmacol., 2015, vol. 753, pp. 125–130.
Bedford, T.G., Tipton, C.M., Wilson, N.C., Oppli-ger, R.A., and Gisolfi, C.V., J. Appl. Physiol. Respir Environ. Exerc. Physiol., 1979, vol. 47, no. 6, pp. 1278–1283.
Turski, W.A., Cavalheiro, E.A., Schwarz, M., Czuczwar, S.J., Kleinrok, Z., and Turski, L., Behav. Brain Res., 1983, vol. 9, no. 3, pp. 315–335.
Racine, R.J., Electroencephalogr Clin. Neurophysiol., 1972, vol. 32, no. 3, pp. 281–294.
Bradford, M.M., Anal. Biochem., 1976, vol. 72, pp. 248–254.
Oboh, G., Ogunsuyi, O.B., Ojelade, M.T., and Akomolafe, S.F., Food Sci. Nutr., 2018, vol. 7, no. 1, pp. 34–43.
Ellman, G.L., Arch. Biochem. Biophys., 1959, vol. 82, no. 1, pp. 70–77.
McEwen, C.M., J. Biol. Chem., 1965, vol. 240, no. 4, pp. 1474–1478.
Ellman, G.L., Courtney, K.D., Andres, V., and Featherstone, R.M., Biochem. Pharmacol., 1961, vol. 7, no. 2, pp. 88–95.
Olagoke, O.C., Afolabi, B.A., and Rocha J.B.T., Mol. Cell. Biochem., 2021, vol. 476, no. 7, pp. 2459–2470.
Livak, K.J. and Schmittgen, T.D., Methods, 2001, vol. 25, no. 4, pp. 402–408.
Jellinger, K.A., Eur. J. Neurol., 2003, vol. 10, no. 5, pp. 431–442.
Nikushkin, E.V., Braslavskiĭ, V.E., and Kryzhanovskiĭ, G.N., Zh Nevropatol Psikhiatr Im S S Korsakova., 1981, vol. 81, no. 7, pp. 1031–1035.
Mori, A., Yokoi, I., Noda. Y., and Willmore, L.J., Acta Med. Okayama, 2004, vol. 58, no. 3, pp. 111–115.
Shih, J.C., Chen, K., and Ridd, M.J., Ann. Rev. Neurosci., 1999, vol. 22, pp. 197–217.
Shih, C.J., Wu, J.B., and Chen, K., J. Neural Transm., 2011, vol. 118, no. 6, pp. 979–986.
Bortolato, M., Chen, K., and Shih, J.C., Adv Drug Deliv. Rev., 2008, vol. 60, no. 13-14, pp. 1527–1533.
Sturza, A., Leisegang, M.S., Babelova, A., Schröder, K., Benkhoff, S., Loot, A.E., Fleming, I., Schulz, R., Muntean, D.M., and Brandes, R.P., Hypertension., 2013, vol. 62, no. 6, pp. 1403–1409.
Lühr, S., Vilches-Herrera, M., Fierro, A., Ramsay, R.R., Edmondson, D.E., Reyes-Parada, M., Cassels, B.K., and Iturriaga-Vásquez, P., Bioorganic Med. Chem., 2010, vol. 18, no. 5, pp. 1906–1915.
Braakman, H.M.H., Vaessen, M.J., Jansen, J.F.A., Debeij-Van Hall, M.H.J.A., De Louw, A., Hofman, P.A.M., Vles, J.S.H., Aldenkamp, A.P., and Backes, W.H., Epilepsia., 2013, vol. 54, no. 2, pp. 273–282.
Hermann, B.P., Jones, J.E., Sheth, R., Koehn, M., Becker, T., Fine, J., Allen, C.A., and Seidenberg, M., Epilepsia., 2008, vol. 49, no. 5, pp. 506–511.
Sidhu, M.K., Stretton, J., Winston, G.P., Symms, M., Thompson, P.J., Koepp, M.J., and Duncan, J.S., Neurol., 2015, vol. 84, no. 15, pp. 1512–1519.
Yüksel, A., Cengiz, M., Seven, M., and Ulutin. T., J. Basic Clin. Physiol. Pharmacol., 2000, vol. 11, no. 1, p. 73.
Brigo, F. and Del Felice, A., Cochrane Database Syst. Rev., 2012, no. 3, CD006967.
Deckers, C.L.P., Hekster, Y.A., Keyser, A., Van Lier, H.J.J., Meinardi, H., and Renier, W.O., Epilepsia., 2001, vol. 42, no. 11, pp. 1387–1394.
Abrahams, S., Haylett, W.L., Johnson, G., Carr, J.A., and Bardien, S., Neuroscience., 2019, vol. 406, pp. 1–21.
Aggarwal, B.B., Sundaram, C., Malani, N., and Ichikawa, H., Adv. Exp. Med. Biol., 2007, vol. 595, pp. 1–75.
Guo, J., Cao, X., Hu, X., Li, S., and Wang, J., BMC Pharmacol. Toxicol., 2020, vol. 21, no. 1, p. 5.
Mohammadi, A., Fazeli, B., Taheri, M., et al., Biomed. Pharmacother., 2017, vol. 85, pp. 383–389.
Mehla, J., Reeta, K.H., Gupta, P., and Gupta, Y.K., Life Sci., 2010, vol. 87, no. 19-22, pp. 596–603.
Isackson, P.J., Huntsman, M.M., Murray, K.D., and Gall, C.M., Neuron., 1991, vol. 6, no. 6, pp. 937–948.
Nair, A. and Vaidya, V.A., J. Biosci., 2006, vol. 31, no. 3, pp. 423–434.
Rivera, C., Li, H., Thomas-Crusells, J, et al., J. Cell Biol., 2002, vol. 159, no. 5, pp. 747–752.
Quesseveur, G., David, D.J., Gaillard, M.C., et al., Transl. Psychiatry., 2013, vol. 3, e253.
Mazumder, A.G., Sharma, P., Patial, V., and Singh, D., J. Ethnopharmacol., 2017, vol. 202, pp. 260–273.
Häfele, C.A., Rombaldi, A.J., Häfele, V., et al., Motriz Rev. Educ. Fis., 2020, vol. 26, no. 4, e10200397.
Spencer, J.P.E., Br. J. Nutr., 2008, vol. 99, E-Suppl 1, ES60–ES77.
Wang, H., Xu, J., Lazarovici, P., Quirion, R., and Zheng, W., Front. Mol. Neurosci., 2018, vol. 11, p. 255.
Moosavi, F., Hosseini, R., Saso, L., and Firuzi, O., Drug Des. Devel. Ther., 2015, vol. 9, pp. 4383–4402.
ACKNOWLEDGMENTS
Ogunsuyi O.B. is grateful to the International Brain Research Organization (IBRO) for their support towards this work through the 2020 IBRO Return Home Fellowship Award.
Funding
The study was funded by the International Brain Research Organization (IBRO) Return Home Fellowship, 2020.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest. The authors declare that they have no conflict of interest.
Ethical approval. The handling and use of the animals were in accordance with institutional ethical guide and NIH guide for the care and use of laboratory animals.
Informed consent. The authors gave their consent for the publication of this article.
Additional information
Corresponding author; address: Department of Biomedical Technology, School of Basic Medical Sciences, Federal University of Technology, Akure, P.M.B. 704, Nigeria; e-mail: obogunsuyi@futa.edu.ng, opeyemiogunsuyi@gmail.com.
Rights and permissions
About this article
Cite this article
Ogunsuyi, O.B., Aro, P.O., Umar, H.I. et al. Administration of Curcumin plus Treadmill Exercise Modulate Some Neuronal Enzyme Activities, Redox Markers and BDNF mRNA Expression in Pilocarpine-Induced Epileptic Seizure in Rats. Neurochem. J. 17, 467–476 (2023). https://doi.org/10.1134/S1819712423030145
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1819712423030145